EnerVenue closes US$300 million Series B for 30,000-cycle nickel-hydrogen battery manufacturing
EnerVenue, the US company commercialising technology adapted from nickel-hydrogen batteries, has closed a US$300 million extension of its Series B preferred stock financing round.